Sponsor or institution
Clinical trials and research at Viatris Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Viatris Inc. that are recruiting, at sites in 2 countries (most in United States (3), Germany (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 2 (1), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MR-146 in Neurotrophic Keratopathy: a first-in-human dose escalation and blinded comparison | Phase 1/2 | Sun City, Arizona and 10 other locations | Recruiting | Nov 6, 2026 |
| Gabapentin and oxycodone: does it increase abuse potential in healthy opioid users? | Phase 4 | Overland Park, Kansas | Recruiting | Sep 10, 2026 |
| Contraceptive patch designed to stop ovulation | Phase 2 | Berlin | Recruiting | Jan 26, 2026 |
| Cenerimod added to standard treatment for active lupus nephritis | Phase 3 | Doral, Florida and 13 other locations | Recruiting | Oct 1, 2025 |
All recruiting trials (4)
-
MR-146 in Neurotrophic Keratopathy: a first-in-human dose escalation and blinded comparison
This study tests MR-146 to see if it’s safe and works for adults with stage 1 or 2 neurotrophic keratopathy.
-
Gabapentin and oxycodone: does it increase abuse potential in healthy opioid users?
This study tests whether gabapentin, with or without oxycodone, is more appealing or risky for abuse in healthy adults who have used opioids recreationally.
-
Contraceptive patch designed to stop ovulation
This trial tests whether a norelgestromin transdermal patch can keep ovulation suppressed for 84 days even when users make intentional application mistakes, in healthy women aged 18–35.
-
Cenerimod added to standard treatment for active lupus nephritis
This study will test whether taking cenerimod along with regular treatment helps adults with systemic lupus and active lupus nephritis improve their kidney function and is safe to use.
Quick answers
How many clinical trials run by Viatris Inc. are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.